Product Images Oxaliplatin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Oxaliplatin NDC 71288-171 by Meitheal Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 100 mg Carton - oxali 100mg carton v2
PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 100 mg Vial Label - oxali 100mg vial v2
PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 50 mg Carton - oxali 50mg carton v2
PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 50 mg Vial Label - oxali 50mg vial v2
Figure 1 - oxali fig 1
Figure 2 - oxali fig 2
Figure 3 - oxali fig 3 v2
The text provided is a table showing the percentage of patients surviving and the median survival for different treatment combinations. The first row shows the percentages of patients surviving, with the values being 100%. The second row shows the median survival in months for three different treatment combinations: Oxaliplatin + 5-FULLV with a median survival of 19.4 months, Oxaliplatin + irinotecan with a median survival of 17.6 months, and Irinotecan + 5FULV with a median survival of 146 months. The remaining numbers (9, 15, 138, 21, 24) do not appear to be related to the survival rates and their meaning is unclear.*
structure - oxali structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.